Preferred Label : Nephrotic syndrome, type 7;
Symbol : NPHS7;
CISMeF acronym : AHUS7; NPHS7;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Nephrotic syndrome, type 7, with membranoproliferative glomerulonephritis;
Included titles and symbols : Hemolytic uremic syndrome, atypical, susceptibility to, 7; Ahus, susceptibility to, 7; AHUS7;
Description : Nephrotic syndrome type 7 is an autosomal recessive renal disease characterized by
onset of nephrotic syndrome with proteinuria usually in the first decade of life.
The disorder is progressive, and some patients develop end-stage renal disease within
several years. Renal biopsy typically shows membranoproliferative glomerulonephritis.
Some patients may benefit from immunosuppressive therapy (summary by Ozaltin et al.,
2013). Atypical hemolytic uremic syndrome-7 is characterized by acute onset in the
first year of life of microangiopathic hemolytic anemia, thrombocytopenia, and renal
failure. After the acute episode, most patients develop chronic renal insufficiency.
Unlike other genetic forms of aHUS, AHUS7 is not related to abnormal activation of
the complement system (summary by Lemaire et al., 2013). For a general phenotypic
description and a discussion of genetic heterogeneity of nephrotic syndrome, see NPHS1
(256300). For a general phenotypic description and a discussion of genetic heterogeneity
of aHUS, see AHUS1 (235400).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the diacylglycerol kinase, epsilon, 64-kD gene (DGKE, 601440.0001);
Laboratory abnormalities : Low serum albumin; Normal serum complement levels;
Prefixed ID : #615008;
Origin ID : 615008;
UMLS CUI : C3554330;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)